Key points are not available for this paper at this time.
Cisplatin is a clinically advanced and highly effective anticancer drug used in the treatment of a wide variety of malignancies, such as head and neck, lung, testis, ovary, breast cancer, etc. However, it has only a limited use in clinical practice due to its severe adverse effects, particularly nephrotoxicity; 20%-35% of patients develop acute kidney injury (AKI) after cisplatin administration. The nephrotoxic effect of cisplatin is cumulative and dose dependent and often necessitates dose reduction or withdrawal. Recurrent episodes of AKI result in impaired renal tubular function and acute renal failure, chronic kidney disease, uremia, and hypertensive nephropathy. The pathophysiology of cisplatin-induced AKI involves proximal tubular injury, apoptosis, oxidative stress, inflammation, and vascular injury in the kidneys. At present, there are no effective drugs or methods for cisplatin-induced kidney injury. Recent in vitro and in vivo studies show that numerous natural products (flavonoids, saponins, alkaloids, polysaccharide, phenylpropanoids, etc.) have specific antioxidant, anti-inflammatory, and anti-apoptotic properties that regulate the pathways associated with cisplatin-induced kidney damage. In this review we describe the molecular mechanisms of cisplatin-induced nephrotoxicity and summarize recent findings in the field of natural products that undermine these mechanisms to protect against cisplatin-induced kidney damage and provide potential strategies for AKI treatment.
Building similarity graph...
Analyzing shared references across papers
Loading...
Chunyan Fang
Chinese Academy of Sciences
Dayong Lou
Wenzhou Medical University
Liqin Zhou
Wenzhou Medical University
Acta Pharmacologica Sinica
Zhejiang University
ZheJiang Institute For Food and Drug Control
Zhuhai People's Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Fang et al. (Tue,) studied this question.
synapsesocial.com/papers/69d8c2508c03fbaff8beffa6 — DOI: https://doi.org/10.1038/s41401-021-00620-9